Diagnosis of cystic fibrosis in the kindred of an infant with CFTR-related metabolic syndrome: Importance of follow-up that includes monitoring sweat chloride concentrations over time

Pediatric Pulmonology

Volumn 49, Issue 3, 2014, Pages

  Williams, Sophia N ^a   Nussbaum, Eliezer ^a   Chin, Terry W ^a   Do, Paul C M ^a   Singh, Kathryn E ^b   Randhawa, Inderpal ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CFTR Mutations; cystic fibrosis; sweat chloride testing

Indexed keywords

CFTR MUTATIONS; CYSTIC FIBROSIS; SWEAT CHLORIDE TESTING;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEONATAL SCREENING; SIBLINGS; SWEAT; SYNDROME;

EID: 84894244421     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22918     Document Type: Article

References (15)

1. Mishra A, Greaves R, Massie J,. The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clin Biochem Rev 2005; 26: 135-153.
2. The California Newborn Screening Program-Newborn Screening News. Upcoming Addition To Newborn Screening: Cystic Fibrosis and Biotinidase Deficiency. Summer 2007. California Department of Public Health, Genetic Disease Branch, Newborn Screening Program.
3. Cystic Fibrosis Foundation., Borowitz D, Parad RB, Sharp JK, Sabadosa KA, robinson KA, Rock MJ, Farrell PM, Sontag MK, Rosenfeld M, Davis SD, Marshall BC, Accurso FJ, Cystic fibrosis foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr 2009; 155: S106-S116.
4. Nelson MR, Adamski CR, Tluczek A,. Clinical practices for intermediate sweat tests following abnormal cystic fibrosis newborn screens. J Cyst Fibros 2011; 10: 460-465.
5. Keiles S, Koepke R, Parad R, Kharrazi M,. California Cystic Fibrosis Newborn Screening Consortium. Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening. J Cyst Fibros 2012; 11: 257-260.
6. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Rock MJ, Campbell PW III,. Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: cystic fibrosis foundation consensus report. J Pediatr 2008; 153: S4-S14.
7. Richards CS, Bradley LA, Amos J, Allitto B, Grody WW, Maddalena A, McGinnis MJ, Prior TW, Popovich BW, Watson MS, Palomaki GE,. Standard and guidelines for CFTR mutation testing. Genet Med 2002; 4: 379-391.
8. Stewart B, Zabner J, Schuber AP, Welsh MJ, McCray PB,. Normal SC values do not exclude the diagnosis of cystic fibrosis. Am J Respir Crit Care Med 1995; 151: 899-903.
9. Taylor CJ, Hardcastle J, Southern KW,. Physiological measurements confirming the diagnosis of cystic fibrosis: the sweat test and measurements of transepithelial potential difference. Paediatr Respir Rev 2009; 10: 220-226.
10. Massie J, Gaskin K, Van Asperen P, Wilcken B,. Sweat testing following newborn screening for cystic fibrosis. Pediatr Pulmonol 2000; 29: 452-456.
11. Stern RC,. The diagnosis of cystic fibrosis. N Engl J Med 1997; 336: 487-491.
12. Rosenstein BJ, Cutting GR,. The diagnosis of cystic fibrosis: a consensus statement. J Pediatr 1998; 132: 589-595.
13. Castellani C, Tamanini A, Mastella G,. Protracted neonatal hypertrypsinogenaemia, normal SC, and cystic fibrosis. Arch Dis Child 2000; 82: 481-482.
14. Desmarquest P, Feldmann D, Tamalat A, Boule M, Fauroux B, Tournier G, Clement A,. Genotype analysis and phenotypic manifestations of children with intermediate SC test results. Chest 2000; 118: 1591-1597.
15. Williams S, Chin T, Randhawa I, Nussbaum E,. Possible eventual positive sweat chloride test results in children with CFTR-related metabolic syndrome (CRMS). Pediatr Pulmonol Suppl 2011; 34: 423.